News

PharmaDerm, the branded dermatology business of Sandoz, will be responsible for the sales and marketing of KERYDIN. On July 8, 2014, Anacor announced that the U.S. Food and

This whole process has been part of a company-wide initiative to provide TFS’s clients around the globe with increased performance, functionality and better business decision making tools. OmniComm

The team will collect and integrate previously-siloed medical and research data to advance knowledge and expedite research inquiries for families affected by Phelan-McDermid Syndrome (PMS), a very rare

Stem Cell Factor is a critical cytokine which contributes to cell migration, proliferation, and survival of cardiac stem cells. Researchers at the Cardiovascular Research Center at Icahn School

The grant will support preclinical studies evaluating ThermoDox, the Company’s heat-activated liposomal encapsulation of doxorubicin, in combination with High Intensity Focused Ultrasound (HIFU), for the treatment of brain

PIXUVRI in Israel is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (aggressive B-cell NHL) who have received

Avanir intends to start the trial by evaluating AVP-786 for the adjunctive treatment of major depressive disorder (MDD) during the third quarter of 2014. Avanir Pharmaceuticals chief medical

The Phase II trial is designed to compare a four-week dose-ranging regimen of once-daily oral SP-333 (1mg, 3mg and 6mg) against placebo in patients taking opioid analgesics for

The Phase III trial showed that EYLEA 2mg in both treatment groups (dosed monthly or every two months), showed a sustained improvement from baseline in best corrected visual